OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out LLY/  DE000GG1ZYV6  /

EUWAX
25/06/2024  18:37:03 Chg.+0.99 Bid19:24:55 Ask19:24:55 Underlying Strike price Expiration date Option type
27.18EUR +3.78% 27.22
Bid Size: 10,000		 27.25
Ask Size: 10,000		 Eli Lilly and Co 610.5422 USD 31/12/2078 Call
TeleTrader 16:23 Lilly partners with OpenAI to combat drog-resistance bacteria
GlobeNewswire 21/06 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 14/06 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost
TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 13/05 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 08/05 Erasca Reports First Quarter 2024 Business Updates and Financial Results
GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO